Advantages and limitations of microarray technology in human cancer.
about
Feature extraction and signal processing for nylon DNA microarraysGene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles.Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signaturesSystems Medicine as an Emerging Tool for Cardiovascular GeneticsMeta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancerGlobal gene expression profiling: a complement to conventional histopathologic analysis of neoplasia.Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcomeA new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.Quality control in microarray assessment of gene expression in human airway epitheliumMapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosusMicroarray applications in cancer research.Identification of differently expressed genes in human colorectal adenocarcinomaUnderstanding protein-nanoparticle interaction: a new gateway to disease therapeutics.Average rank-based score to measure deregulation of molecular pathway gene setsInsights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cellsWhen tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry--the red, brown, and blue technique.Spatial patterns of genome-wide expression profiles reflect anatomic and fiber connectivity architecture of healthy human brain.Transcriptomic profiles differentiate normal rectal epithelium and adenocarcinoma.Methods for transcriptional profiling in plants. Be fruitful and replicate.Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodelingMolecular diagnosis of ATP-binding cassette transporter-related diseases.Chipping into the human genome: novel insights for transplantation.Lipidomic strategies to study structural and functional defects of ABC-transporters in cellular lipid trafficking.In praise of arrays.The glycobiology of brain tumors: disease relevance and therapeutic potential.Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations.Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).SILAC-Based Quantitative Proteomic Analysis Unveils Arsenite-Induced Perturbation of Multiple Pathways in Human Skin Fibroblast Cells.Multi-membership gene regulation in pathway based microarray analysis.Advantages of RNA-seq compared to RNA microarrays for transcriptome profiling of anterior cruciate ligament tears.Rapid assessment of drug response in cancer cells using microwell array and molecular imaging.Integrating RNA sequencing into neuro-oncology practice.9G DNAChip Technology: Self-Assembled Monolayer (SAM) of ssDNA for Ultra-Sensitive Detection of Biomarkers.Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.Transcriptome Profiling in Systems Vascular MedicinePhosphosite-Specific Antibodies: A Brief Update on Generation and Applications.Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer.
P2860
Q24791649-FAA2F6D1-AED0-44C4-8D1D-2A7B28A3A5CDQ24810251-CEF4AFB2-0BF0-4FEF-A858-FB76DD4DED16Q24810564-49858DCF-5745-4D82-A7AA-76359A3639F9Q24812541-D215686D-87E9-430F-83C6-858165A993E2Q28069197-7B368921-1AE4-4BED-A2D9-9D992F888848Q30656824-190FFA88-5228-480F-8192-BEB74345FDEAQ33227605-5369D4B1-9E2D-46D2-A38F-39F145B53A55Q33299765-FB03A0B3-AEAF-4185-8568-14B763D3EB8AQ33314438-FDC0D242-59F5-45CE-A3CC-0C4CED03DF96Q33512143-DF4154AB-D7F2-4CEF-8BF8-2EDB47C11945Q33614670-2C13E3FC-B65A-457D-B9E9-073255E6F81AQ33746903-C731457F-B18F-4A32-9091-1DCD53C40ECAQ33868086-C7A1DCFC-629C-4612-A9EA-5C29931C3ED6Q34025939-5335C3FF-1283-4C50-B771-1175C7A72D89Q34077968-0EEE5FC8-273D-4688-AF4E-F9CF0A1BA8B0Q34353406-A95A68F9-A022-4C89-A89A-BEF467FC27E0Q34377983-BACA2400-45A5-4DC2-B3D4-F60B0F68ECFCQ34817175-72B8FB58-6E20-42E1-AC0D-B16328AA800EQ35676166-753ECE81-5705-490E-9E5A-FE6215399A5DQ35790165-8037D830-6CC9-44A2-873E-B828A933ECA2Q35824472-8F84F223-C247-47B3-AAD1-9C265763B70AQ36228895-7404F60F-BD4E-4359-9BD8-3C3EF37B49C3Q36252201-D07A51B4-E4DC-428C-B3D0-0F2B3584892CQ36453368-63F3FDF2-E8A5-4C8A-B4DD-5474CD45AB6EQ36578069-E9ED1ACD-F023-4816-8881-73FB5874F2E1Q37196276-BEC89348-929A-4C46-B5E1-7599D5A758B3Q37615367-EAE65EA0-CC97-4A81-B00D-DCF88EDFAF87Q38010665-0B859515-4200-4DE0-969D-E87051A0BEA3Q38301721-C59574E2-ACA5-455D-B158-5251CA156946Q38403001-7C4B7335-283A-4430-A8D4-8E63B6FD99D4Q38652500-114B837B-BF0A-4F0A-8D37-8467AA612B12Q38658133-BAB1B305-3783-4826-93F1-EADA14F20057Q39001610-76FEF84D-A036-4F63-9746-FA427A734474Q39459649-3F5623DE-829F-4E79-87E0-EC3B1B5C2259Q40045582-08561B96-51B4-47C0-B11A-EB328E4FD3ADQ42270789-C06058F8-4DDD-42F5-95C2-4811C89A7662Q42362541-E9575108-D804-4584-96EB-201CA3E046DCQ46420104-44BB0ACB-9276-4A1E-A90E-C6979FA18329Q46803214-7A6F8576-DD00-434E-8FF2-EDFE0CD7CE28Q47938015-33C46D5C-8409-4241-877D-78C356FB25C9
P2860
Advantages and limitations of microarray technology in human cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Advantages and limitations of microarray technology in human cancer.
@ast
Advantages and limitations of microarray technology in human cancer.
@en
type
label
Advantages and limitations of microarray technology in human cancer.
@ast
Advantages and limitations of microarray technology in human cancer.
@en
prefLabel
Advantages and limitations of microarray technology in human cancer.
@ast
Advantages and limitations of microarray technology in human cancer.
@en
P2860
P356
P1433
P1476
Advantages and limitations of microarray technology in human cancer.
@en
P2093
Charles Zegar
Giuseppe Russo
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206865
P407
P577
2003-09-01T00:00:00Z